18 results
Polyarteritis Nodosa (PAN) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Severe Disease → Remission
) - Vasculitis Management ... Algorithm - ACR ... /VF 2021 Guidelines ... • Severe Disease ... • Non-Severe Disease
Cholinesterase Inhibitor (ChEl) and Memantine Deprescribing Algorithm 

To support health care professionals in employing the recommendations
Deprescribing Algorithm ... outlined in the guideline ... This algorithm helps ... professionals decide ... #Management #Geriatrics
Deprescribing algorithm for proton pump inhibitors

To support clinicians in employing the recommendations outlined in the guideline,
Deprescribing algorithm ... outlined in the guideline ... This algorithm helps ... clinicians decide ... #Management #Geriatrics
Hyperkalemia management algorithm 2023-2024 based on UKKA and KDIGO guidelines.

#hyperkalemia #electrolytes #algorithm #emergency #management

Notes:

(1) Up to
Hyperkalemia management ... UKKA and KDIGO guidelines ... #emergency #management ... recent UKKA, 2023 guidelines ... advice 30ml (effective
Algorithm for Suspected Cardiovascular Implantable Electronic Device (CIED) Pocket Infection
Algorithm for Management of bacteremia without evidence
Implantable Electronic Device ... for Management ... #Pocket #device ... #diagnosis #management ... cardiology #CIED #IDSA #Guideline
JNC8 blood pressure goals for the treatment of hypertension are a lot simpler than they may
diagram shows the algorithm ... chronic kidney disease ... the 2017 ACC/AHA guidelines ... #hypertension #management ... #algorithm
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment algorithms ... Obstructive Lung Disease ... #Management #Pulmonary ... LAMA #LABA #ICS #Guidelines
COPD Management Algorithm - GOLD 2019 guidelines 

Categorize into COPD GOLD A-D -> Initiate first-line therapy
COPD Management ... Algorithm - GOLD ... bronchodilators or change devices ... #Management #Pulmonary ... #Algorithm #pharmacology
Non-alcoholic fatty liver disease algorithm.
 
For those patients with NAFLD or liver disease of unknown aetiology,
algorithm. ... NAFLD or liver disease ... tailored to the device ... #NAFLD #algorithm ... #Referral #Management
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
coronary artery disease ... fraction; GDMT, guideline-directed ... Stages #ACCAHA #Algorithm ... #Management #Cardiology